Exhibit 99.1

MEDCATH CORPORATION
SUPPLEMENTAL FINANCIAL DISCLOSURE
(Presenting Heart Hospital of Austin as a Discontinued Operation for Each Period Presented)
(In thousands)
(Unaudited)

The following table reflects net income from continuing and discontinued operations attributable to noncontrolling interest for all periods presented.

	Fiscal Year										Fiscal Year
	Ended		Quarter Ended		Quarter Ended		Quarter Ended		Quarter Ended		Ended		Quarter Ended
	September 30,		December 31,		March 31,		June 30,		September 30,		September 30,		December 31,
	2008		2008		2009		2009		2009		2009		2009
Net income attributable to noncontrolling interests:
Net income from continuing operations attributable to noncontrolling interest	$	11,611	$	2,049	$	3,766	$	1,868	$	458	$	8,141	$	706
Net income from discontinued operations attributable to noncontrolling interest		10,247		1,074		699		404		7,187		9,364		135
Total net income attributable to noncontrolling interests	$	21,858	$	3,123	$	4,465	$	2,272	$	7,645	$	17,505	$	841

The following table reconciles the income (loss) from continuing operations, net of taxes attributable to MedCath Corporation’s common stockholders as derived directly from MedCath Corporation’s consolidated statement of operations, as furnished in Exhibit 99.2 filed with Form 8-K on February 17, 2010, to Adjusted EBITDA for all periods presented.

	Fiscal Year															Fiscal Year
	Ended			Quarter Ended			Quarter Ended			Quarter Ended			Quarter Ended			Ended			Quarter Ended
	September 30,			December 31,			March 31,			June 30,			September 30,			September 30,			December 31,
	2008			2008			2009			2009			2009			2009			2009
Income (loss) from continuing operations, net of taxes	$	9,727		$	(2,627	)	$	4,129		$	(65	)	$	(62,769	)	$	(61,331	)	$	(3,159	)
Add:
Income tax expense (benefit)		8,365			(1,402	)		2,701			258			(1,611	)		(54	)		(1,834	)
Net income from continuing operations attributable to noncontrolling interest		11,611			2,049			3,766			1,868			458			8,141			706
Equity in net earnings of unconsolidated affiliates		(7,891	)		(2,065	)		(2,714	)		(2,265	)		(2,013	)		(9,057	)		(1,516	)
Interest and other income		(2,011	)		(101	)		(73	)		(47	)		(9	)		(230	)		(71	)
Loss on early extinguishment of debt		—			6,961			(259	)		—			—			6,702			—
Interest expense		11,261			2,097			581			396			697			3,771			1,058
Impairment of goodwill		—			—			—			—			60,174			60,174			—
Loss (gain) on disposal of property, equipment and other assets		217			73			108			(54	)		137			264			96
Amortization		32			8			8			8			867			891			8
Depreciation		25,259			6,496			6,217			6,466			7,232			26,411			7,650
Pre-opening expenses		786			207			380			754			2,222			3,563			866
Share-based compensation expense		4,978			998			839			231			322			2,390			608
Adjusted EBITDA	$	62,334		$	12,694		$	15,683		$	7,550		$	5,707		$	41,635		$	4,412